A detailed history of Marshall Wace, LLP transactions in Absci Corp stock. As of the latest transaction made, Marshall Wace, LLP holds 1,304,761 shares of ABSI stock, worth $4.34 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,304,761
Previous 1,833,902 28.85%
Holding current value
$4.34 Million
Previous $5.65 Million 11.76%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.97 - $4.49 $1.57 Million - $2.38 Million
-529,141 Reduced 28.85%
1,304,761 $4.98 Million
Q2 2024

Aug 14, 2024

BUY
$2.92 - $6.58 $1.01 Million - $2.28 Million
347,079 Added 23.34%
1,833,902 $5.65 Million
Q1 2024

May 15, 2024

BUY
$3.41 - $5.74 $4.27 Million - $7.19 Million
1,252,881 Added 535.55%
1,486,823 $8.45 Million
Q4 2023

Feb 14, 2024

BUY
$1.15 - $4.79 $140,923 - $586,976
122,542 Added 110.0%
233,942 $982,000
Q3 2023

Nov 14, 2023

BUY
$1.28 - $2.41 $142,592 - $268,474
111,400 New
111,400 $147,000

Others Institutions Holding ABSI

About Absci Corp


  • Ticker ABSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 92,843,504
  • Market Cap $309M
  • Description
  • Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....
More about ABSI
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.